We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Pharmacovigilance – Products

Product News

Avacta Announces Second Dose Escalation in the Phase I Clinical Study of AVA6000 Pro-Doxorubicin

Avacta Group plc announces that the first-in-human Phase I trial of AVA6000 Pro-doxorubicin will advance to the third dose cohort following a positive review of the safety data from the dosing of the second cohort.
Product News

Precision BioSciences Provides Update on Allogeneic CAR T Programs and Path Forward With its Lead PBCAR0191 Candidate for CAR T Relapsed Patient Population

Precision BioSciences, Inc., has announced its latest program updates across its allogeneic CAR T pipeline.
Product News

Waters Introduces High Resolution Mass Spectrometry Products and Software To Accelerate Drug Development

Waters Corporation has unveiled new instruments, software and product enhancements to drive drug discovery and development at the American Society for Mass Spectrometry 2022 Annual Conference.
Product News

Agilent Announces the Innovative Seahorse XF Pro Analyzer

Agilent Technologies Inc. has announced the release of the Agilent Seahorse XF Pro Analyzer, featuring new pharma-oriented workflow solutions incorporating advanced experimental design and analysis tools.
Product
Advertisement

Charged Aerosol Detectors - Ensure Vaccine Efficacy

Charged Aerosol detection (CAD) can be used to complement your HPLC-UV analysis in a situation where excipients in a formula are a mix of UV active and inactive components. Using these tools together gives you a robust and reliable analytical detection method to determine the stability of all vaccine excipients.
Whitepaper

Protein Biomarkers Show Promise in Predicting Patient Response to Cancer Immunotherapies

Cancer immunotherapy relies on activating or enhancing the antitumor immune response and has taken a central position in cancer treatment modalities. However, not all patients respond to immunotherapy, and combination immunotherapies increase cost of treatment and heighten the risk for toxicity-related adverse events.
Product
Advertisement

SomaScan Assay: The World's Largest Proteomic Platform

Discover more with the first and only technology that can measure 7,000 proteins over a broad range of concentrations. Built on 20 years of pioneering proteomics technology, The SomaScan Assay enables unprecedented biomarker and drug discovery and now, you can seamlessly transition from discovery to validation with new SomaScan panels and SomaSignal TM Tests bolstering the entire drug discovery and development pipeline, all via a straightforward fee-for-service model.
Product News

Research Reveals Trivalent PROTACs More Potent in Targeted Protein Degradation

Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in targeted protein degradation.
App Note / Case Study

Applications Using Human Liver Spheroids

Recently, the advantages of PHH liver spheroids use in liver toxicity tests over the traditional 2D monolayer culture of PHHs has been demonstrated by many scientists.
Whitepaper

Validation Guidance for Residual Host Cell DNA Testing

Development of a manufacturing process for a biotherapeutic that ensures consistent quality, purity and safety is a critical step in successfully developing the drug, getting it approved by regulatory agencies, and bringing it to the market.
Advertisement